J&J CEO Joaquin Duato on cancer treatments, M&A outlook and ‘most favored nation’ policy

CNBC’s Angelica Peebles and Johnson & Johnson chairman and CEO Joaquin Duato join ‘Squawk Box’ to discuss the company’s 5-year multiple myeloma treatment study, the company’s cancer treatments, M&A outlook, ‘most favored nation’ pricing, and more.